HAL (France)open access
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF Cohort
Prognosis, 0, Hepatocellular carcinoma HCC, Outcomes, 1, 2, Systemic treatments, Immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 280440
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.